Telehealth collaborative care program for lung cancer-related anxiety and depression
Increasing Adoption of a Telehealth-Delivered Collaborative Care Program for Patients With Lung Cancer: A Pilot Study
This project tests whether a more intensive 'high-touch' outreach approach gets more people with lung cancer who have anxiety or depression to join a telehealth collaborative care program than standard outreach.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Abramson Cancer Center at Penn Medicine Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT07102147 on ClinicalTrials.gov |
What this trial studies
This pilot interventional trial randomizes patients treated at Penn Medicine Thoracic Oncology to receive either a high-touch outreach strategy or standard outreach to invite them into a telehealth-delivered collaborative care model (CoCM) for depression and/or anxiety. The primary outcome is program reach (how many referred patients enroll and engage), and secondary outcomes include implementation measures and clinical effectiveness outcomes for mental health symptoms. Participants are adults referred to Penn's CoCM program who are not already receiving external psychotherapy, with exclusion for significant untreated medical or psychiatric comorbidities. The project builds on prior evidence that CoCM benefits patients with cancer while specifically testing whether outreach intensity increases telehealth program uptake.
Who should consider this trial
Good fit: Adults (18+) receiving lung cancer treatment or survivorship care at Penn Medicine Thoracic Oncology who are referred for collaborative care for depression or anxiety and are not already in external psychotherapy are ideal candidates.
Not a fit: Patients already receiving psychotherapy outside Penn, or those with significant untreated medical or psychiatric conditions (for example, active suicidal ideation or psychosis) may not benefit from or be eligible for this program.
Why it matters
Potential benefit: If successful, the approach could increase enrollment in effective telehealth mental health care for people with lung cancer, improving access and anxiety/depression outcomes.
How similar studies have performed: Collaborative care models have shown benefit for depression and anxiety in cancer and general populations, but using a high-touch outreach strategy to boost telehealth CoCM enrollment is a newer, pilot-level approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Are aged 18 years or older. * Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care. * Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services. Exclusion Criteria: * Are already receiving psycho-therapy treatment services outside of Penn Medicine's collaborative care program, Penn Integrated Care (PIC). * Have a significant and/or untreated medical and/or psychiatric co-morbidity (e.g., other cancers, schizophrenia, acute suicidal and/or homicidal ideation) that make them ineligible for the Penn CoCM program.
Where this trial is running
Philadelphia, Pennsylvania
- Abramson Cancer Center at the University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Alexandria Muench, PsyD — University of Pennsylvania
- Study coordinator: Jennifer Steltz, MRA
- Email: jennifer.steltz@pennmedicine.upenn.edu
- Phone: 215-573-2593
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.